Does the media prefer KIDS or INSP?

In the previous week, OrthoPediatrics and OrthoPediatrics both had 5 articles in the media. Inspire Medical Systems' average media sentiment score of 1.64 beat OrthoPediatrics' score of 0.28 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspire Medical Systems 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor ESTA or KIDS?

In the previous week, Establishment Labs and Establishment Labs both had 5 articles in the media. Establishment Labs' average media sentiment score of 0.70 beat OrthoPediatrics' score of 0.28 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor BFLY or KIDS?

In the previous week, Butterfly Network had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for Butterfly Network and 5 mentions for OrthoPediatrics. Butterfly Network's average media sentiment score of 0.41 beat OrthoPediatrics' score of 0.28 indicating that Butterfly Network is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to KIDS or NVCR?

In the previous week, NovoCure had 3 more articles in the media than OrthoPediatrics. MarketBeat recorded 8 mentions for NovoCure and 5 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.28 beat NovoCure's score of 0.27 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NovoCure 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to KIDS or LMAT?

In the previous week, LeMaitre Vascular had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for LeMaitre Vascular and 5 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.28 beat LeMaitre Vascular's score of 0.28 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LeMaitre Vascular 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

OrthoPediatrics (KIDS) Competitors

$22.33 -0.43 (-1.89%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$22.34 +0.02 (+0.07%)

As of 09/23/2026 07:30 PM Eastern

Compare

KIDS vs. INSP, ESTA, BFLY, NVCR, and LMAT

Should you buy OrthoPediatrics stock or one of its competitors? OrthoPediatrics's main competitors and comparable companies include Inspire Medical Systems (INSP), Establishment Labs (ESTA), Butterfly Network (BFLY), NovoCure (NVCR), and LeMaitre Vascular (LMAT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does OrthoPediatrics compare to Inspire Medical Systems?

OrthoPediatrics (NASDAQ:KIDS) and Inspire Medical Systems (NYSE:INSP) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 32.5% of OrthoPediatrics shares are held by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, OrthoPediatrics and OrthoPediatrics both had 5 articles in the media. Inspire Medical Systems' average media sentiment score of 1.64 beat OrthoPediatrics' score of 0.28 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspire Medical Systems	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

OrthoPediatrics presently has a consensus price target of $26.44, suggesting a potential upside of 18.43%. Inspire Medical Systems has a consensus price target of $66.50, suggesting a potential downside of 3.72%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Inspire Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Inspire Medical Systems	3 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	2.21

Inspire Medical Systems has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.47	-$39.65M	-$1.68	N/A
Inspire Medical Systems	$898.74M	2.22	$145.42M	$4.62	14.95

OrthoPediatrics has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

Inspire Medical Systems has a net margin of 15.03% compared to OrthoPediatrics' net margin of -15.72%. Inspire Medical Systems' return on equity of 8.64% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
Inspire Medical Systems	15.03%	8.64%	7.45%

Summary

Inspire Medical Systems beats OrthoPediatrics on 10 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and OrthoPediatrics (NASDAQ:KIDS) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Establishment Labs has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market.

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Comparatively, 32.5% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

OrthoPediatrics has a net margin of -15.72% compared to Establishment Labs' net margin of -15.82%. OrthoPediatrics' return on equity of -8.10% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
OrthoPediatrics	-15.72%	-8.10%	-5.54%

Establishment Labs currently has a consensus price target of $100.25, suggesting a potential upside of 47.95%. OrthoPediatrics has a consensus price target of $26.44, suggesting a potential upside of 18.43%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Establishment Labs is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

OrthoPediatrics has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$245.82M	8.21	-$51.06M	-$1.31	N/A
OrthoPediatrics	$236.35M	2.47	-$39.65M	-$1.68	N/A

In the previous week, Establishment Labs and Establishment Labs both had 5 articles in the media. Establishment Labs' average media sentiment score of 0.70 beat OrthoPediatrics' score of 0.28 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Establishment Labs beats OrthoPediatrics on 8 of the 15 factors compared between the two stocks.

How does OrthoPediatrics compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and OrthoPediatrics (NASDAQ:KIDS) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

In the previous week, Butterfly Network had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for Butterfly Network and 5 mentions for OrthoPediatrics. Butterfly Network's average media sentiment score of 0.41 beat OrthoPediatrics' score of 0.28 indicating that Butterfly Network is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Butterfly Network has a beta of 2.08, indicating that its share price is 108% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market.

OrthoPediatrics has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$112.14M	21.92	-$77.06M	-$0.29	N/A
OrthoPediatrics	$236.35M	2.47	-$39.65M	-$1.68	N/A

Butterfly Network currently has a consensus price target of $7.25, indicating a potential downside of 21.47%. OrthoPediatrics has a consensus price target of $26.44, indicating a potential upside of 18.43%. Given OrthoPediatrics' stronger consensus rating and higher possible upside, analysts plainly believe OrthoPediatrics is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

OrthoPediatrics has a net margin of -15.72% compared to Butterfly Network's net margin of -66.74%. OrthoPediatrics' return on equity of -8.10% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-66.74%	-33.99%	-22.96%
OrthoPediatrics	-15.72%	-8.10%	-5.54%

37.8% of Butterfly Network shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 22.0% of Butterfly Network shares are owned by company insiders. Comparatively, 32.5% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

OrthoPediatrics beats Butterfly Network on 11 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to NovoCure?

OrthoPediatrics (NASDAQ:KIDS) and NovoCure (NASDAQ:NVCR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership, profitability and media sentiment.

OrthoPediatrics currently has a consensus target price of $26.44, suggesting a potential upside of 18.43%. NovoCure has a consensus target price of $21.20, suggesting a potential upside of 30.46%. Given NovoCure's higher probable upside, analysts clearly believe NovoCure is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
NovoCure	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, NovoCure has a beta of 1.01, indicating that its share price is 1% more volatile than the broader market.

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 84.6% of NovoCure shares are held by institutional investors. 32.5% of OrthoPediatrics shares are held by insiders. Comparatively, 6.6% of NovoCure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

OrthoPediatrics has higher earnings, but lower revenue than NovoCure. OrthoPediatrics is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.47	-$39.65M	-$1.68	N/A
NovoCure	$699.19M	2.71	-$136.23M	-$1.30	N/A

OrthoPediatrics has a net margin of -15.72% compared to NovoCure's net margin of -21.25%. OrthoPediatrics' return on equity of -8.10% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
NovoCure	-21.25%	-44.00%	-15.85%

In the previous week, NovoCure had 3 more articles in the media than OrthoPediatrics. MarketBeat recorded 8 mentions for NovoCure and 5 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.28 beat NovoCure's score of 0.27 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NovoCure	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

OrthoPediatrics and NovoCure tied by winning 8 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to LeMaitre Vascular?

OrthoPediatrics (NASDAQ:KIDS) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

LeMaitre Vascular has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.47	-$39.65M	-$1.68	N/A
LeMaitre Vascular	$249.60M	7.38	$57.73M	$2.85	28.27

In the previous week, LeMaitre Vascular had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for LeMaitre Vascular and 5 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.28 beat LeMaitre Vascular's score of 0.28 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LeMaitre Vascular	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

LeMaitre Vascular has a net margin of 25.02% compared to OrthoPediatrics' net margin of -15.72%. LeMaitre Vascular's return on equity of 15.63% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
LeMaitre Vascular	25.02%	15.63%	10.06%

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 32.5% of OrthoPediatrics shares are held by company insiders. Comparatively, 7.4% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

OrthoPediatrics presently has a consensus price target of $26.44, suggesting a potential upside of 18.43%. LeMaitre Vascular has a consensus price target of $110.60, suggesting a potential upside of 37.25%. Given LeMaitre Vascular's higher possible upside, analysts clearly believe LeMaitre Vascular is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

LeMaitre Vascular beats OrthoPediatrics on 11 of the 16 factors compared between the two stocks.

Get OrthoPediatrics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KIDS vs. The Competition

Export

Metric	OrthoPediatrics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$594.26M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-13.29	25.26	274.08	25.69
Price / Sales	2.47	71.56	638.21	78.99
Price / Cash	136.87	33.02	77.80	52.76
Price / Book	1.62	5.78	10.47	6.32
Net Income	-$39.65M	$151.55M	$3.49B	$359.73M
7 Day Performance	2.53%	-0.01%	-0.67%	0.17%
1 Month Performance	-10.93%	-3.53%	-3.17%	-3.27%
1 Year Performance	18.21%	6.37%	15.14%	5.58%

OrthoPediatrics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KIDS OrthoPediatrics	3.8987 of 5 stars	$22.33 -1.9%	$26.44 +18.4%	+17.9%	$594.26M	$236.35M	N/A	602
INSP Inspire Medical Systems	3.2979 of 5 stars	$74.66 +0.5%	$66.50 -10.9%	-10.3%	$2.15B	$911.98M	16.16	1,333	Analyst Downgrade
ESTA Establishment Labs	2.9164 of 5 stars	$71.48 -0.6%	$100.25 +40.2%	+59.1%	$2.14B	$211.08M	N/A	1,004	Positive News Analyst Forecast
BFLY Butterfly Network	1.4966 of 5 stars	$7.77 +4.9%	$6.56 -15.6%	+351.4%	$1.97B	$97.61M	N/A	220	Trending News Analyst Forecast
NVCR NovoCure	2.6291 of 5 stars	$16.15 -0.4%	$21.20 +31.3%	+25.0%	$1.89B	$655.35M	N/A	1,605	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KIDS) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OrthoPediatrics (KIDS) Competitors

KIDS vs. INSP, ESTA, BFLY, NVCR, and LMAT

How does OrthoPediatrics compare to Inspire Medical Systems?

Summary

How does OrthoPediatrics compare to Establishment Labs?

Summary

How does OrthoPediatrics compare to Butterfly Network?

Summary

How does OrthoPediatrics compare to NovoCure?

Summary

How does OrthoPediatrics compare to LeMaitre Vascular?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OrthoPediatrics (KIDS) Competitors

KIDS vs. INSP, ESTA, BFLY, NVCR, and LMAT

How does OrthoPediatrics compare to Inspire Medical Systems?

Do insiders and institutionals hold more shares of KIDS or INSP?

Does the media prefer KIDS or INSP?

Do analysts prefer KIDS or INSP?

Which has better earnings and valuation, KIDS or INSP?

Which has more risk and volatility, KIDS or INSP?

Is KIDS or INSP more profitable?

Summary

How does OrthoPediatrics compare to Establishment Labs?

Which has more volatility and risk, ESTA or KIDS?

Do insiders & institutionals hold more shares of ESTA or KIDS?

Is ESTA or KIDS more profitable?

Do analysts rate ESTA or KIDS?

Which has better valuation and earnings, ESTA or KIDS?

Does the media favor ESTA or KIDS?

Summary

How does OrthoPediatrics compare to Butterfly Network?

Does the media favor BFLY or KIDS?

Which has more risk and volatility, BFLY or KIDS?

Which has stronger valuation and earnings, BFLY or KIDS?

Do analysts prefer BFLY or KIDS?

Is BFLY or KIDS more profitable?

Do insiders and institutionals believe in BFLY or KIDS?

Summary

How does OrthoPediatrics compare to NovoCure?

Do analysts prefer KIDS or NVCR?

Which has more risk and volatility, KIDS or NVCR?

Do institutionals and insiders hold more shares of KIDS or NVCR?

Which has preferable earnings & valuation, KIDS or NVCR?

Is KIDS or NVCR more profitable?

Does the media refer more to KIDS or NVCR?

Summary

How does OrthoPediatrics compare to LeMaitre Vascular?

Which has more volatility and risk, KIDS or LMAT?

Which has stronger valuation & earnings, KIDS or LMAT?

Does the media refer more to KIDS or LMAT?

Is KIDS or LMAT more profitable?

Do institutionals & insiders hold more shares of KIDS or LMAT?

Do analysts prefer KIDS or LMAT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools